当前位置: X-MOL 学术Heart Vessels › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prognostic predictors and echocardiographic time course after device replacement in patients treated chronically with cardiac resynchronization therapy devices
Heart and Vessels ( IF 1.5 ) Pub Date : 2021-09-09 , DOI: 10.1007/s00380-021-01940-w
Takahiko Nagase 1 , Maya Ishiguro 1 , Kei Mabuchi 1 , Ruiko Seki 1 , So Asano 1 , Hiroshi Fukunaga 1 , Kanki Inoue 1 , Yukio Sekiguchi 1 , Kohei Tanizaki 1 , Mamoru Nanasato 1 , Nobuo Iguchi 1 , Junichi Nitta 1 , Mitsuaki Isobe 1
Affiliation  

The prognostic predictors of death or heart failure hospitalization and the echocardiographic response after initial cardiac resynchronization therapy (CRT) device replacement (CRT-r) remain unclear. We evaluated the predictors and the echocardiographic time course in patients after CRT-r. Consecutive 60 patients underwent CRT-r because of battery depletion. Patients were divided into two groups depending on the chronic echocardiographic response to CRT (left ventricular end-systolic volume [LVESV] reduction of ≥ 15%) at the time of CRT-r: CRT responders (group A; 35 patients) and CRT nonresponders (group B; 25 patients). The primary endpoint was a composite of death from any cause or heart failure hospitalization. Changes in LVESV and left ventricular ejection fraction (LVEF) after CRT-r were also analyzed. During the mean follow-up of 46 ± 33 months after CRT-r, the primary endpoint occurred more frequently in group B (group A versus group B; 8/35 [23%] patients versus 19/25 [76%] patients, p < 0.001). No significant changes in LVESV and LVEF were observed at the mean of 46 ± 29 months after CRT-r in both groups. A multivariate analysis identified echocardiographic nonresponse to CRT, chronic kidney disease, atrial fibrillation, and New York Heart Association functional class III or IV at the time of CRT-r as independent predictors of the primary endpoint in all patients. Residual echocardiographic nonresponse, comorbidities, and heart failure symptoms at the time of CRT-r predict the subsequent very long-term prognosis after CRT-r. No further echocardiographic response to CRT was found after CRT-r.



中文翻译:

长期使用心脏再同步治疗装置治疗的患者更换装置后的预后预测因子和超声心动图时间进程

死亡或心力衰竭住院的预后预测因子以及初始心脏再同步治疗 (CRT) 装置更换 (CRT-r) 后的超声心动图反应仍不清楚。我们评估了 CRT-r 后患者的预测因子和超声心动图时间进程。由于电池耗尽,连续 60 名患者接受了 CRT-r。根据 CRT-r 时对 CRT 的慢性超声心动图反应(左心室收缩末期容积 [LVESV] 减少 ≥ 15%)将患者分为两组:CRT 反应者(A 组;35 名患者)和 CRT 无反应者(B组;25名患者)。主要终点是全因死亡或心力衰竭住院的复合终点。还分析了 CRT-r 后 LVESV 和左心室射血分数 (LVEF) 的变化。p  < 0.001)。在 CRT-r 后平均 46 ± 29 个月,两组的 LVESV 和 LVEF 均未观察到显着变化。多变量分析确定超声心动图对 CRT 无反应、慢性肾病、心房颤动和 CRT-r 时纽约心脏协会功能分级 III 或 IV 作为所有患者主要终点的独立预测因素。CRT-r 时残留的超声心动图无反应、合并症和心力衰竭症状可预测 CRT-r 后随后的极长期预后。CRT-r 后未发现对 CRT 的进一步超声心动图反应。

更新日期:2021-09-09
down
wechat
bug